Gastrointestinal Drugs
265 FDA-approved drugs
TheraRadar tracks 265 FDA-approved gastrointestinal drugs from 141 companies across 20 drug classes, led by GSK, with 243 active clinical trials in the pipeline. Explore recent approvals, top companies, active trials by indication, and drug classes for Gastrointestinal.
Gastrointestinal Approvals by Year
4
'15
4
'16
6
'17
4
'18
2
'19
5
'20
3
'21
3
'22
3
'23
4
'24
1
'25
'26
Recent Gastrointestinal Drug Approvals
ELUXADOLINE
ELUXADOLINE
2025-03-14
ASCEND LABORATORIES, LTD
PRUCALOPRIDE SUCCINATE
PRUCALOPRIDE SUCCINATE
chronic idiopathic constipation (CIC) in adults...
2024-12-26
ZENARA
METHYLNALTREXONE BROMIDE
METHYLNALTREXONE BROMIDE
2024-08-26
Teva
PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE
PANTOPRAZOLE SODIUM
pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome in adults...
2024-02-14
Baxter
H+/K+ ATPase
EOHILIA
BUDESONIDE
12 weeks of treatment in adult and pediatric patients 11 years of age and older with eosinophilic es...
2024-02-09
Takeda
Glucocorticoid receptor
VOQUEZNA
VONOPRAZAN FUMARATE
VOQUEZNA is indicated: for healing of all grades of erosive esophagitis and relief of heartburn asso...
2023-11-01
PHATHOM PHARMACEUTICALS INC
H+, K+-ATPase
XPHOZAH
TENAPANOR HYDROCHLORIDE
XPHOZAH is indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialy...
2023-10-17
ARDELYX INC
NHE3
SUFLAVE
MAGNESIUM SULFATE
the cleansing of the colon as a preparation for colonoscopy in adults...
2023-06-15
AZURITY
SINCALIDE
SINCALIDE
Sincalide for Injection is indicated in adults to: stimulate gallbladder contraction, as may be asse...
2022-11-22
MAIA PHARMS INC
Cholecystokinin receptor
APONVIE
APREPITANT
the prevention of postoperative nausea and vomiting (PONV) in adults...
2022-09-16
HERON THERAPS INC
NK1R
KONVOMEP
OMEPRAZOLE
KONVOMEP is indicated in adults for: short-term treatment (4 to 8 weeks) of active benign gastric ul...
2022-08-30
AZURITY
H+/K+ ATPase
DARTISLA ODT
GLYCOPYRROLATE
2021-12-16
EDENBRIDGE PHARMS
LUBIPROSTONE
LUBIPROSTONE
chronic idiopathic constipation (CIC) in adults...
2021-11-30
AMNEAL
ClC-2
LINACLOTIDE
LINACLOTIDE
2021-02-09
Aurobindo Pharma
SUTAB
MAGNESIUM SULFATE
the cleansing of the colon as a preparation for colonoscopy in adults...
2020-11-10
AZURITY
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
CHLORDIAZEPOXIDE HYDROCHLORIDE
INDICATIONS AND USAGE: Chlordiazepoxide hydrochloride and clidinium bromide capsules is indicated to...
2020-07-07
MISEMER
GIMOTI
METOCLOPRAMIDE HYDROCHLORIDE
the relief of symptoms in adults with acute and recurrent diabetic gastroparesis...
2020-06-19
QOL MEDCL
BARHEMSYS
AMISULPRIDE
BARHEMSYS ® is indicated in adults for: prevention of postoperative nausea and vomiting (PONV), eith...
2020-02-26
LXO IRELAND
PIZENSY
LACTITOL
2020-02-12
BRAINTREE LABS
ALVIMOPAN
ALVIMOPAN
Alvimopan capsules are indicated to accelerate the time to upper and lower gastrointestinal recovery...
2019-12-19
WATSON LABS TEVA
Mu-opioid receptor
Showing the 20 most recent of 265 gastrointestinal drugs. View all 265 →
Top Gastrointestinal Companies
Gastrointestinal Active Trials by Indication
243 active trials — the forward pipeline, not just approvals.
All competitive landscapes →Gastrointestinal Drug Classes
Osmotic Laxative 6
Proton Pump Inhibitor 5
Cholecystokinin Analog 2
Chloride Channel Activator 2
Guanylate Cyclase-C Agonist 2
Anticholinergic 2
Histamine-2 Receptor Antagonist 2
Aluminum Complex 2
Corticosteroid 1
Substance P/Neurokinin-1 Receptor Antagonist 1
Gastrointestinal at a Glance
- Total Drugs
- 265
- Companies
- 141
- Drug Classes
- 20
- Active Trials
- 243
- Latest Approval
- 2025-03-14